Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Real-World Effectiveness of Pegylated Liposomal Doxorubicin Versus Paclitaxel in Platinum- Sensitive Recurrent Ovarian Cancer

NCT03562533 is registered in ClinicalTrials.gov with Konkuk University Medical Center as lead sponsor.

NCT NCT03562533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03562533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Real-World Effectiveness of Pegylated Liposomal Doxorubicin Versus Paclitaxel in Platinum- Sensitive Recurrent Ovarian Cancer
Lead sponsor
Konkuk University Medical Center
Phase
Observational
Overall status
Completed
Start date
May 17, 2018
Completion date
December 17, 2018
Enrollment
432 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian carcinoma